Hiv Research & Clinical Practice

Hiv Research & Clinical Practice英文簡(jiǎn)介

HIV Research and Clinical Practice is devoted to presenting information on the latest ;developments in HIV/AIDS clinical and translational research, as well as advances in care that directly affect clinical practice. This journal enables readers to obtain the most up-to-date, innovative research from around the world.In an era of increasingly well tolerated antiretroviral therapy (ART) much focus of research in the HIV field is examining the complex interplay of inflammation, ageing, and the development of chronic comorbidities in persons living with HIV infection (PLWH). HIV Research and Clinical Practice aims to provide an authoritative forum for this area, with a focus on impactful clinical and translational research, as well as advances in clinical care. This international, peer-reviewed journal also intends to publish research undertaken with strong implementation science principles, whether supporting testing and treatment for HIV, best practices in prevention, or acute or chronic aspects of HIV care. The overarching principle is to improve quality of care, and quality of life, for all PLWH.

Hiv Research & Clinical Practice中文簡(jiǎn)介

《Hiv Research & Clinical Practice》是一本由TAYLOR & FRANCIS LTD出版商出版的專業(yè)醫(yī)學(xué)期刊，刊期6 issues/year，該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄。在中科院最新升級(jí)版分區(qū)表中，該刊分區(qū)信息為大類學(xué)科：醫(yī)學(xué) 4區(qū)，小類學(xué)科：傳染病學(xué) 4區(qū)；藥學(xué) 4區(qū)；在JCR（Journal Citation Reports）分區(qū)等級(jí)為Q4。該刊發(fā)文范圍涵蓋傳染病學(xué)等領(lǐng)域，旨在及時(shí)、準(zhǔn)確、全面地報(bào)道國(guó)內(nèi)外傳染病學(xué)工作者在該領(lǐng)域取得的最新研究成果、工作進(jìn)展及學(xué)術(shù)動(dòng)態(tài)、技術(shù)革新等，促進(jìn)學(xué)術(shù)交流，鼓勵(lì)學(xué)術(shù)創(chuàng)新。2021年影響因子為1.676，

中科院分區(qū)最新升級(jí)版（當(dāng)前數(shù)據(jù)版本：2021年12月最新升級(jí)版）

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)	Top期刊	綜述期刊
醫(yī)學(xué)	4區(qū)	INFECTIOUS DISEASES 傳染病學(xué) PHARMACOLOGY & PHARMACY 藥學(xué)	4區(qū) 4區(qū)	否	否

JCR分區(qū)（當(dāng)前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級(jí)	JCR所屬學(xué)科	分區(qū)	影響因子
Q4	PHARMACOLOGY & PHARMACY	Q4	1.676
	INFECTIOUS DISEASES	Q4

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
1.676	--	16.36%	90.48%	未開放	--

IF值(影響因子)趨勢(shì)圖